Catherine T. Doherty $DGX SEC Form 4 Insider Trading

Catherine T. Doherty has filed a total of 30 insider trades in $DGX since 2021. Their most recent trade was a sale of 5,558 shares, made on Mar 05, 2026. Their largest trade was a sale of 28,300 shares, made on Nov 27, 2024. We estimate that they now own 67,122 shares of $DGX, worth an estimated $13.4 million.

Insider Trading at $DGX

There have been a total of 132 insider trades reported at $DGX since 2021, with 0 shares purchased and 1.2 million shares sold. The most active insider traders in $DGX stock have been Michael E Prevoznik, J. E. Davis, and Stephen H Rusckowski. The most recent trade was a sale of 5,558 shares reported by Catherine T. Doherty (EVP, Regional Businesses), made on Mar 05, 2026.

$DGX Executives and Stock Owners with Insider Trades

• Michael E Prevoznik, SVP & General Counsel

• J. E. Davis, CEO and President

• Stephen H Rusckowski, Chairman, CEO and President

• Catherine T. Doherty, EVP, Regional Businesses

• Patrick Plewman, SVP for Diagnostic Services

• Karthik Kuppusamy, SVP, Clinical Solutions

• Catherine T. Doherty, SVP, Group Exec. Clin. Fran.

• Michael J Deppe, SVP, Corp. Controller & CAO

• Catherine T. Doherty, SVP, Regional Businesses

• Mark E Delaney, SVP & Chief Commercial Officer

• Michael J Deppe, VP, Corp. Controller & CAO

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.